Spotlight
Specialty
Partners
CME/CE
Concluding Remarks in Lung Cancer Screening Following COVID-19
The 6-person panel concludes the discussion on lung cancer screening following the COVID-19 pandemic with an interactive question and answer session revolving around shared decision making, nonsmoker patient screening options, and molecular testing via standard tissue.
EP: 1.Introducing the Post-Pandemic Change With Lung Cancer Screening
EP: 2.Opportunities and Challenges With Lung Cancer Screening Following COVID-19
EP: 3.How to Reduce Lung Cancer Screening Disparities After COVID-19
EP: 4.The Effects of COVID-19 and Vaccinations in Non–Small Cell Lung Cancer
EP: 5.Therapeutic Approaches in Small Cell Lung Cancer
EP: 6.2021 USPSTF Lung Cancer Screening Recommendations
Now Viewing
EP: 7.Concluding Remarks in Lung Cancer Screening Following COVID-19
The 6-person panel concludes the discussion on lung cancer screening following the COVID-19 pandemic with an interactive question and answer session revolving around shared decision making, nonsmoker patient screening options, and molecular testing via standard tissue.
Related Videos
